Prospective Multicentre Randomized Double-Blind Placebo-Controlled Parallel Group Study on the Efficacy and Tolerability of StroVac� in Patients With Recurrent Symptomatic Bacterial Urinary Tract Infections
Read time: 1 mins
Last updated:21st Nov 2011
To demonstrate the clinical efficacy and tolerability of the inactivated germs of specified enterobacteria contained in StroVac� in recurrent acute uncomplicated symptomatic bacterial urinary tract infections as compared to placebo.
|Study start date||2011-11-21|